HomeNTRA • NASDAQ
Natera Inc
add
$144.50
3.20%
After Hours:(0.00%)0.00
$144.50
Closed: Mar 12, 4:40:54 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 476.06M | 53.02% |
Operating expense | 364.38M | 49.09% |
Net income | -53.77M | 31.09% |
Net profit margin | -11.29 | 54.98% |
Earnings per share | -0.41 | 35.94% |
EBITDA | -60.45M | 24.46% |
Effective tax rate | 2.46% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 968.28M | 10.16% |
Total assets | 1.66B | 15.19% |
Total liabilities | 465.32M | -31.20% |
Total equity | 1.20B | — |
Shares outstanding | 135.19M | — |
Price to book | 15.54 | — |
Return on assets | -9.95% | — |
Return on capital | -11.83% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -53.77M | 31.09% |
Cash from operations | 52.89M | 191.81% |
Cash from investing | -11.12M | -146.05% |
Cash from financing | 10.97M | 60.32% |
Net change in cash | 52.74M | 298.17% |
Free cash flow | 54.05M | 231.70% |
Previous close
$140.02
Day range
$143.35 - $149.77
Year range
$83.13 - $183.00
Market cap
19.08B USD
Avg Volume
1.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Founded
Jan 1, 2004
Headquarters
Website
Employees
4,429
